Navigation Links
LabStyle Innovations to Deliver Poster Presentation at American Diabetes Association's 75th Scientific Sessions on June 5-9, 2015 in Boston
Date:4/22/2015

CAESAREA, Israel, April 22, 2015 /PRNewswire/ -- LabStyle Innovations Corp. (OTCQB:DRIO), developer of the Dario™ Diabetes Management Solution, today reported that the American Diabetes Association (ADA) has selected the Company's abstract titled, "Performance of Dario Blood Glucose Monitoring System Evaluated in a Clinical Study in Compliance with the New ISO 15197:2013 Standard," as a Late Breaking Poster Presentation at the ADA's 75th Anniversary Scientific Sessions.  

Dr. Paul Rosman, a member of the LabStyle Innovations Scientific Advisory Board, will deliver the presentation on Sunday, June 7th from 12:00 PM - 2:00 PM at the Boston Convention and Exhibition Center. The ADA's Scientific Sessions brings together over 14,000 participants from 124 countries. The program will feature the most timely and significant advances in science and the prevention, diagnosis, and treatment of diabetes.

"We look forward to presenting the important results of our Dario Blood Glucose Monitoring System's performance study to key opinion leaders and healthcare providers focused on the treatment of diabetes.  We recently submitted data from this study to the U.S. Food and Drug Administration as part of our 510K application for marketing clearance in the U.S.," stated Erez Raphael, LabStyle's President and Chief Executive Officer.

About LabStyle InnovationsLabStyle Innovations Corp. (OTCQB:DRIO) develops and commercializes patented technology providing consumers with laboratory-testing capabilities using smart mobile devices. LabStyle's flagship product is the Dario™ Diabetes Management Solution. Dario™ empowers people with diabetes to take charge of their health with the right tools, insights, and support in their pocket.  With access to both real-time and historical blood glucose data, Dario™ is designed to spot patterns, recommend the right treatments and support behavior change efforts.

Dario™ is a platform that combines an all-in-one, blood glucose meter, smart phone application (iOS & Android), website application and treatment tools to support more proactive and better informed decisions by patients, doctors and healthcare systems. The stylish and compact self-monitoring system combines a lancet to obtain a blood sample, a proprietary disposable test strip cartridge and a smartphone-driven glucose meter. LabStyle Innovations is led by an experienced management team with vast software, medical device and technology experience and is guided by a world class board of directors and scientific advisory board. For more information: www.myDario.com and http://myDario.investorroom.com.

Cautionary Note Regarding Forward-Looking StatementsThis news release and the statements of representatives and partners of LabStyle Innovations Corp. (the "Company") related thereto contains or may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the generality of the foregoing, words such as "plan," "project," "potential," "seek," "may," "will," "expect," "believe," "anticipate," "intend," "could," "estimate" or "continue" are intended to identify forward-looking statements. Readers are cautioned that certain important factors may affect the Company's actual results and could cause such results to differ materially from any forward-looking statements that may be made in this news release. Factors that may affect the Company's results include, but are not limited to, regulatory approvals, product demand, market acceptance, impact of competitive products and prices, product development, commercialization or technological difficulties, the success or failure of negotiations and trade, legal, social and economic risks, and the risks associated with the adequacy of existing cash resources. Additional factors that could cause or contribute to differences between the Company's actual results and forward-looking statements include, but are not limited to, those risks discussed in the Company's filings with the U.S. Securities and Exchange Commission. Readers are cautioned that actual results (including, without limitation, the timing for and results of the Company's commercial and regulatory plans for Dario™ as described herein) may differ significantly from those set forth in the forward-looking statements. The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law. Contacts: Press and Investor Relations Brenda Zeitlin

LabStyle Innovations1 800 896 9062Brenda@mydario.com 


'/>"/>
SOURCE LabStyle
Copyright©2015 PR Newswire.
All rights reserved

Related medicine technology :

1. LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors
2. LabStyle Innovations Reports 2014 Second Quarter Results and Anticipated Milestones for the Remainder of the Year
3. LabStyle Innovations Closes $4.2 Million Non-Brokered Private Placement Financing
4. LabStyle Innovations Common Stock to Resume Trading Under the Symbol "DRIO"
5. LabStyle Innovations Announces 2014 Third Quarter Results and Provides Business Update
6. LabStyle Innovations Announces HMO Tele-Care Partnership Agreement
7. LabStyle Innovations Raises $1.6 Million in a Non-Brokered Private Placement Financing
8. LabStyle Innovations Announces Successful Results from User Performance Evaluation Study to Support 510(k) Application and Announces Appointment of VP Regulatory
9. LabStyle Innovations Submits Data to U.S. FDA from Successfully Concluded 368 Patient Clinical Study of Dario Diabetes Management Solution for 510(k) Marketing Clearance
10. LabStyle Innovations Announces 2014 Year End Results and Reports First Time Revenues from Global Rollout of Dario
11. CPhI Opens Awards to Global Pharma Industry, Celebrating Tomorrows Innovations Today
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2021)... ... March 29, 2021 , ... The University of Texas Health Science Center ... San Antonio Multispecialty and Research Hospital, a destination center for research and treatment of ... In a nod to the COVID-19 pandemic, the ceremony was held virtually. , William ...
(Date:3/30/2021)... ... March 29, 2021 , ... Iora Health ... primary care, has partnered with Devoted Health , one of the fastest-growing ... across Maricopa County and provides seniors with the highest-quality care and experience possible, ...
(Date:3/30/2021)... CITY (PRWEB) , ... March 29, 2021 , ... ... has joined the Vaccine Credential Initiative (VCI), a group bringing together leading health ... record of vaccination status, based on open, interoperable standards. By joining the VCI ...
Breaking Medicine Technology:
(Date:3/30/2021)... , ... March 29, 2021 , ... ... the 21st Century , A Virtual Workshop Presented by WCG FDAnews and Cerulean ... 4:30 pm EDT, https://wcg.swoogo.com/modern-sop-and-quality-systems , Are one’s SOPs written for the ...
(Date:3/30/2021)... ... March 29, 2021 , ... According to data released ... reproductive age (13-44) in need of publicly funded contraception live in counties impacted by ... Colorado’s 64 counties have lost some of their Title X resources. , The ...
(Date:3/30/2021)... ... March 29, 2021 , ... Health Literacy Innovations (HLI), a ... confusion due to low health literacy today announces a new partnership with the ... work with ACAP’s member Safety Net Health Plans, those that provide comprehensive health ...
(Date:3/30/2021)... ... ... Dr. Colin Campbell is proud to announce the 1 year anniversary in their new state ... internal medicine and is a primary care specialist who has been practicing for 23 years. ... keep South Jersey healthy one patient at a time. , “Over the past year, Dr. ...
(Date:3/30/2021)... ... March 30, 2021 , ... The COVID-19 ... and survivors; their families; and their caregivers. Crossroads4Hope is addressing the needs of ... emotional support system, MyGo2Support, which meets needs of people impacted by cancer, no ...
Breaking Medicine News(10 mins):